Continuous Femoral Nerve Block Versus Local-wound Infiltration Analgesia For Patients Receiving Total Knee Arthroplasty --- A Randomized Controlled Trial
Postoperative Pain, Total Knee Arthroplasty
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring anesthesia, nerve block, infltration
Eligibility Criteria
Inclusion Criteria:
- men and women over the 18 years and younger than 75 years old who had received selective unilateral knee replacement.
Exclusion Criteria:
- bilateral knee replacement
- the secondary knee revision and knee surgery not interfering with articular joint cavity (wound debridement and suture)
- American Society of Anesthesiology (ASA) classification of anesthesia risk IV and V grade; body mass index higher than 35
- coagulation dysfunction, which is assessed by activated partial thromboplastin time (APTT) higher than the upper limit by 10s
- prothrombin time (PT) higher than the upper limit by 5s
- International Normalized Ratio (INR) higher than 1.3, or any of criteria met above
- local infection of puncture sites
- neurological diseases
- uncontrolled general infection
- intra-operative cardiac arrest.
Sites / Locations
- The First Affliated Hospital of Chongqing Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
CFNB group
LWI group
Particiants in this group will receive a single injection for femoral nerve block intra-operatively combined continuous femoral nerve block post-operatively. This technique will be guided by ultrasound and nerve stimulator.The regimen is a loading dose of 0.8% ropivacaine 30 ml intra-operatively and 0.15% ropivacaine 300ml in the form of continuous femoral nerve block post-operatively.
Particiants in this group will receive a peri-articular injection of suspension (48 ml of 0.8% ropivacaine with 2 ml of 40mg methylprednisolone) combined with intravenous patient controlled analgesia post-operatively (tramadol 800 mg and flurbiprofenaxetil 100 mg with saline added up to a volume of 80 ml )